Literature DB >> 8298277

Cell wall antigens in Aspergillus fumigatus.

J P Latge1, J P Debeaupuis, J Sarfati, M Diaquin, S Paris.   

Abstract

The Aspergillus cell wall contains most of the antigens secreted by the fungus during its active in vitro or in vivo growth. These antigens, which bind to the IgE and IgG of allergic and aspergilloma patients or are secreted in the biological fluids of patients with invasive aspergillosis, are of primary importance in the diagnosis of aspergillosis. Located at the interface between host and pathogen cells, the fungal cell wall plays a major role during fungal invasion. It contains several surface receptors involved in adhesion of the fungus to host proteins and cells. Some of the wall antigens are also directly involved in the colonization of the host tissues by the fungus. Very few of these putative virulence factors have been purified until now. A 33-kDa alkaline protease of the subtilisin family can hydrolyze several extracellular matrix proteins such as collagen, fibrinogen, elastin. However, gene disruption experiments have shown that protease-deficient mutants are still able to infect mice. An 18-kDa antigen, which has been detected in the urine of patients with invasive aspergillosis, is present in vivo in the lung of mice infected with A. fumigatus. It has a ribonuclease activity that cleaves a single phosphodiester bond in a highly conserved region of the ribosomal RNA. Its role in the virulence of A. fumigatus has not been demonstrated until now. Biochemical and molecular characterization of the wall antigenic aggressins should be pursued.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8298277

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  8 in total

1.  Production and characterization of recombinant Aspergillus fumigatus Cu,Zn superoxide dismutase and its recognition by immune human sera.

Authors:  M D Holdom; B Lechenne; R J Hay; A J Hamilton; M Monod
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Use of recombinant mitogillin for improved serodiagnosis of Aspergillus fumigatus-associated diseases.

Authors:  M Weig; M Frosch; K Tintelnot; A Haas; U Gross; B Linsmeier; J Heesemann
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages.

Authors:  T Madan; P Eggleton; U Kishore; P Strong; S S Aggrawal; P U Sarma; K B Reid
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

4.  Fungal cell wall septation and cytokinesis are inhibited by bleomycins.

Authors:  Carol W Moore; Judith McKoy; Robert Del Valle; Donald Armstrong; Edward M Bernard; Norman Katz; Ronald E Gordon
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

5.  Specific recognition of purified Cu,Zn superoxide dismutase from Aspergillus fumigatus by immune human sera.

Authors:  A J Hamilton; M D Holdom; R J Hay
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

6.  H-ficolin binds Aspergillus fumigatus leading to activation of the lectin complement pathway and modulation of lung epithelial immune responses.

Authors:  Stefan Bidula; Darren W Sexton; Matthew Yates; Alireza Abdolrasouli; Anand Shah; Russell Wallis; Anna Reed; Darius Armstrong-James; Silke Schelenz
Journal:  Immunology       Date:  2015-08-24       Impact factor: 7.397

7.  An Ssd1 Homolog Impacts Trehalose and Chitin Biosynthesis and Contributes to Virulence in Aspergillus fumigatus.

Authors:  Arsa Thammahong; Sourabh Dhingra; Katherine M Bultman; Joshua D Kerkaert; Robert A Cramer
Journal:  mSphere       Date:  2019-05-08       Impact factor: 4.389

8.  Aspergillus terreus accessory conidia are unique in surface architecture, cell wall composition and germination kinetics.

Authors:  Eszter Deak; Selwyn D Wilson; Elizabeth White; Janice H Carr; S Arunmozhi Balajee
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.